Results 131 to 140 of about 15,159,360 (304)

On the Dynamics of Some Higher-Order Nonlinear Difference Equations

open access: yesMathematics
This research investigates the dynamics of higher-order nonlinear difference equations, specifically concentrating on seventh-order instances. Analytical solutions are obtained for particular equations, a formidable task owing to the absence of explicit ...
Turki D. Alharbi, Md Rifat Hasan
doaj   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Arbitrariness of the General Solution and Symmetries

open access: yesActa Applicandae Mathematicae, 1995
Results of the author [J. Math. Phys. 35, No. 1, 486-498 (1994; Zbl 0803.35143)] concerning the computation of the number of arbitrary functions in the general solution of a system of involutive PDEs are briefly reviewed. They are used to study normal systems and their symmetry reductions. The computation of the number of physical degrees of freedom in
openaire   +5 more sources

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

General Fund, Transportation Fund and spending cap projections; General Fund and Transportation Fund budget projections and fiscal information; General Fund & Transportation Fund budget projections

open access: yes, 2010
Two or three issues a year; Vol. for FY 07/FY 09 General Fund covers FY 07/FY 12 Transportation Fund budget projections.; Harvested from the web on 9/30 ...

core   +1 more source

First Integral and General Solution of the Reduced Nonlinear Third-Order Differential Equation with a Nonlinear Source

open access: yesMathematics
We consider a generalization of the modified Korteweg–de Vries–Burgers equation with a nonlinear source. Using the Painlevé test for partial differential equation with the Kruskal variable, we show that the corresponding Cauchy problem cannot be solved ...
Nikolay A. Kudryashov
doaj   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Solution-Focused Collective Action: A Response to Harry Korman, Peter De Jong, and Sara Smock Jordan

open access: yes, 2021
The July 2021 edition of this journal carried both a response (Shennan, 2021) to the article Steve de Shazer’s Theory Development (Korman et al., 2020), and a reply to that response by the article’s authors (Korman et al., 2021). These authors gave their
Collective, Solution-Focused
core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy